Rhadbomyolysis associated with co-administration of danazol and lovastatin

Khanna S, Sahil Khanna, Mundell WC, William C Mundell
British journal of clinical pharmacology · 2011 · vol. 72(1) , pp. 166–7 · doi:10.1111/j.1365-2125.2011.03901.x · PMID:21223355 · PMC3141201
Case report OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-14 ⓘ

This paper reports a case of rhabdomyolysis occurring in a patient treated concurrently with danazol and lovastatin.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Anticholesteremic Agents Danazol Estrogen Antagonists Lovastatin Rhabdomyolysis Aged, 80 and over Anticholesteremic Agents Danazol Dose-Response Relationship, Drug Drug Interactions Estrogen Antagonists Humans Lovastatin Male Rhabdomyolysis White People

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:08:28.697392+00:00
unpaywall
last seen: 2026-10-25T06:24:14.523685+00:00